- Report
- May 2022
- 40 Pages
Saudi Arabia
From €1421EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
Russia
From €1421EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
Japan
From €1421EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
Ireland
From €1421EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
India
From €1421EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
Germany
From €1421EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
France
From €1421EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
China
From €1421EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
Brazil
From €1421EUR$1,500USD£1,200GBP
- Report
- January 2024
- 250 Pages
Global
€4733EUR$4,995USD£3,995GBP
- Report
- September 2023
- 114 Pages
Global
From €2795EUR$2,950USD£2,359GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2795EUR$2,950USD£2,359GBP
- Report
- September 2023
- 89 Pages
From €2795EUR$2,950USD£2,359GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3269EUR$3,450USD£2,759GBP
- Report
- September 2023
- 112 Pages
Europe
From €3269EUR$3,450USD£2,759GBP
- Report
- September 2023
- 101 Pages
North America
From €2795EUR$2,950USD£2,359GBP
- Report
- September 2023
- 194 Pages
Global
From €4691EUR$4,950USD£3,959GBP
- Report
- March 2021
- 137 Pages
Global
From €4643EUR$4,900USD£3,919GBP
- Drug Pipelines
- January 2018
- 18 Pages
Global
From €9476EUR$10,000USD£7,997GBP
- Drug Pipelines
- January 2018
- 16 Pages
Global
From €9476EUR$10,000USD£7,997GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more